Major and Minor Classifications for Surgery in People With Hemophilia: A Literature Review.

Autor: Solimeno LP; 1 Emergency Trauma Department, IRCCS Cà Granda Foundation, Maggiore Hospital, Milan, Italy., Escobar MA; 2 Department of Internal Medicine and Pediatrics, University of Texas, Health Science Center and the Gulf States Hemophilia and Thrombophilia Center, Houston, TX, USA., Krassova S; 3 Novo Nordisk Health Care AG, Zurich, Switzerland., Seremetis S; 4 Novo Nordisk Inc, Plainsboro, NJ, USA.
Jazyk: angličtina
Zdroj: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2018 May; Vol. 24 (4), pp. 549-559. Date of Electronic Publication: 2017 Jul 06.
DOI: 10.1177/1076029617715117
Abstrakt: Agents that control bleeding and the usage of bypassing agents have made surgery an option to consider in people with hemophilia. However, the lack of consistent definitions for major or minor surgery may lead to inconsistencies in patient management. This literature review has evaluated how surgical procedures in people with hemophilia were categorized as major or minor surgery and assessed the consistency across publications. After screening 926 potentially relevant articles, 547 were excluded and 379 full-text articles were reviewed. Ninety-five articles categorized major or minor surgical procedures; of these, 35 publications categorized three or more major or minor surgical procedures and were included for analysis. Seven (20%) publications provided varying criteria for defining major or minor surgery, five of which defined surgery according to the level of surgical invasiveness. Across all 35 publications, there was considerable variance in the categorization of major and minor surgical procedures and some overlap in surgical nomenclature (eg, type of synovectomy, arthroscopy, and central venous access device insertion/removals). The lack of consistent guidance when referring to major or minor surgery in people with hemophilia needs to be addressed. Clear and consistent definitions, achieved by consensus and promoted by relevant international hemophilia committees, are desirable, to provide guidance on appropriate treatment, to increase the accuracy of trial data and may confound the interpretation of surgical outcomes.
Databáze: MEDLINE